Samed Verep

Samed Verep

Auto-generated profile, based on publicly available information

Samed Verep

Department of Urology, Private Yuzyil Gebze Hospital, Kocaeli, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2019 in The Prostate
Verified
Journal Article
Closed access
PDF file
SVSamed Verep
Samed Verep
SESelcuk Erdem
Selcuk Erdem
YOYasemin Ozluk
Yasemin Ozluk
IKIsin Kilicaslan
Isin Kilicaslan
OSOner Sanli
Oner Sanli
FOFaruk Ozcan
Faruk Ozcan

28 September 2022 in Urolithiasis
Verified
Journal Article
Closed access
PDF file
MKMehmet Ali Karagöz
Mehmet Ali Karagöz
SGSelcuk Guven
Selcuk Guven
TTTzevat Tefik
Tzevat Tefik
MGMehmet İlKer Gökçe
Mehmet İlKer Gökçe
MKMurat Can Kiremit
Murat Can Kiremit
KSKemal Sarıca
Kemal Sarıca

3 December 2019 in The Prostate
Verified
Journal Article
Closed access
PDF file
SESelcuk Erdem
Selcuk Erdem
SVSamed Verep
Samed Verep
SBSidar Bagbudar
Sidar Bagbudar
YOYasemin Ozluk
Yasemin Ozluk
OSOner Sanli
Oner Sanli
FOFaruk Ozcan
Faruk Ozcan

20 June 2023 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
MKMehmet Kaba
Mehmet Kaba
NPNecip Pirinççi
Necip Pirinççi
MDMurat Demir
Murat Demir
SKSultan Kaba
Sultan Kaba
SOSerdar Oztuzcu
Serdar Oztuzcu
SVSamed Verep
Samed Verep

9 February 2024 in Urologic Oncology: Seminars and Original Investigations
Verified
Journal Article
Closed access
MKMehmet Kaba
Mehmet Kaba
NPNecip Pirincci
Necip Pirincci
HDHalit Demir
Halit Demir
SVSamed Verep
Samed Verep

1 June 2023 in Journal of Laparoendoscopic & Advanced Surgical Techniques
Verified
Journal Article
Closed access
MIMuhammed Arif Ibis
Muhammed Arif Ibis
MGMehmet Ilker Gokce
Mehmet Ilker Gokce
OGOkan Gökhan
Okan Gökhan
MKMehmet Ali Karagoz
Mehmet Ali Karagoz
YYYasin Yitgin
Yasin Yitgin
KSKemal Sarıca
Kemal Sarıca
Background: The purpose of this study is to compare the efficacy and safety of extracorporeal shockwave lithotripsy (SWL), retrograde intrarenal surgery (RIRS), mini-percutaneous nephrolithotomy (mPNL), and standard-percutaneous nephrolithotomy (stPNL) for the treatment of 20–30 mm kidney stones. Methods: The records of 1197 patients (SWL = 149, RIRS = 205, mPNL = 525, and stPNL = 318) from 8 centers were reviewed retrospectively. Four procedures were compared for stone-free rates (SFRs), auxiliary treatment, and associated complications. Results: Initial SFRs were 43.6%, 54.6%, 86.7%, and 87.7% in SWL, RIRS, mPNL, and stPNL, respectively (P < .001), whereas the final SFRs were 71.8%, 80%, 90.5%, and 89.6% (P < .001). The rate of auxiliary treatment in the groups was 38.3%, 26.8%, 5%, and 4.4%, respectively (P < .001). The initial and final SFRs in the mPNL and stPNL groups were higher than those in SWL and RIRS groups (P < .001). The rate for auxiliary treatment was lower in the mPNL and stPNL groups (P < .001). The operation time was longer in the RIRS group (P = .005). According to the Clavien–Dindo classification, the complication rate in the SWL group was lower than that in the surgical approaches (P < .001); however, no statistical difference was detected between RIRS, mPNL, and stPNL groups. mPNL and stPNL had a higher success rate than RIRS or SWL for treating 20–30 mm kidney stones. Conclusion: In the treatment of 2–3 cm renal stones, RIRS and PNL were more effective than SWL to obtain a better SFR and less auxiliary treatment rate. Compared with RIRS, mPNL and stPNL provided a higher SFR with similar complication rates.